DWK Life Sciences’ Post

The machine premiers and innovations are a must see if you are attending Achema.

Nice article on how we continue to waste water in the pharmaceutical industry in the A3P Association magazine LaVague by Jean-Emmanuel GILBERT and Stephane Gilbert from AQUASSAY. The hidden costs of this waste will hopefully, at some stage, help us to overcome our change aversion in this otherwise scientifically advanced industry. https://lnkd.in/dV5uP6Um

Hospitals are swamped in packaging waste! Why not reduce your packaging by moving into mono-resin "high barrier spouted pouches". Reduce Ruse and Recycle are equally meaningful in Pharma. And...consider Fuji Seal for the GMO certified distribution of your valuable products.

📢 Calling all ISPE Ireland Affiliate Members! Your Vote is Needed on EU Proposal to Ban PFAS Substances by Q2 2027!    Your opinion is crucial in shaping the future of our pharmaceutical industry. The EU is considering a ban on PFAS substances, commonly present in materials like PTFE, used in tubing, gaskets, valves, and filters. This could impact our processes significantly.   Complete the survey here by the 27th of August. https://lnkd.in/dqQ8Qkcu   Your feedback will be a collective voice representing our industry's interests and concerns. Let's work together for a greener and healthier future. Liz Dooley Carolann Purcell Paul Clarke Eimear Dempsey Catherine Lanigan Kevin Lynch Emer Somers Adrienne Fleming Eamon Judge Elizabeth Falvey Aoife Corcoran Claire Kelleher Michael Schofield Philip Gammell Tom Nyhan Malcolm Goggin   #ISPEIreland #PFASBanEU #PharmaceuticalIndustry #Sustainability

The USAID-funded PQM+ program is partnering with Chemical Process Technologies Process Technologies in #SouthAfrica for the technology transfer of the active pharmaceutical ingredient (API) rifapentine, a drug that treats and prevents #TB. This will add local manufacturing capacity to the African market, making TB treatment more accessible and affordable. PQM+ worked with Virginia Common Wealth University to support development of a more efficient and cost-effective approach to synthesizing and manufacturing the rifapentine API. The program is also partners with the South African Health Products Regulatory Authority to strengthen capacity for API review and inspection. For more information about this exciting innovation, see ow.ly/P5to50QTAsf #HealthSystems

Recently, Tofflon achieved successful registration and public disclosure of a groundbreaking pharmaceutical packaging material: injection-grade cyclic olefin polymer (COP) vials and pre-filled syringe components. This accomplishment was recognized and acknowledged by both the China National Medical Products Administration (CDE) and the U.S. Food and Drug Administration (FDA). 🌟   Cyclic Olefin Polymers (COP) have revolutionized the field of packaging with their exceptional properties. Offering high purity, biocompatibility, and minimal extractables, COP materials overcome the limitations of glass while preserving transparency. COP exhibits numerous advantages, such as safeguarding sensitive biologics, withstanding ultra-low temperatures, and facilitating small-batch production. 🧪✨   Click to read the full white paper for more details: 👇   #COP #pharmaceuticalpackaging #biopharma #lifescience

"Regulatory Framework and Challenges." 🎙️Featuring esteemed speakers Francisco Javier D. (Adamed Pharmaceutical), María José Villarraza (Bioxentys), Roberto Funes (Biosidus), moderated by Elif Ülkü (STADA).   To succeed in the regulatory framework for biosimilars, businesses should prioritize global coverage, draw inspiration from European achievements, and foster homogeneity, cooperation, efficiency, and accessibility. Overcoming challenges such as incompatibility, achieving alignment, adhering to standards, and addressing accessibility issues are essential for practical application and sustainable success.   🔗 Register now: https://lnkd.in/d2b6nViy   See you in Valencia! 🎉   #BiosimilarsLatAm #Europe #BiotechForum #Valencia #Spain #RegulatoryGuidelines #Networking

For almost 100 years, the Apis Bull has been our symbol, a representation of our values. Historically it's been common practice for European chemists to use animal symbols to represent their pharmaceutical companies. Our founders chose the mythical Apis Bull as ours – a symbol of strength and courage 💙 The evolution of our logo: https://lnkd.in/eHtHxQJa #DrivingChange #NovoNordisk100

Get to know the fundamentals of pH measurements. https://okt.to/dC0Iqw #pHMeasurement #pHSensor

Our CEO Katja Richter is on the road! She will be giving a presentation on "Chitosan form various sources as pharmaceutical excipient - regulatory aspects" at this year's Asia-Pacific Chitin and Chitosan Symposium https://apccs2023.org/ . Meet her and members of the HMC team at the conference in Jeju. Learn more from her about: 🔎 What are the differences in using different raw materials (crustaceans, fungi, insects)? 🔎 Which regulatory aspects are important for the medical use of chitosan in Europe? 🔎 What do you need to consider when launching a medical product containing chitosan? #chitosan #apccs2023 #chitosanmanufacturer